Cargando…
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis
Autores principales: | Lemarquis, Andri, Campbell, Tessa, Aranda-Guillén, Maribel, Hennings, Viktoria, Brodin, Petter, Kämpe, Olle, Blennow, Kaj, Zetterberg, Henrik, Wennerås, Christine, Eriksson, Kristina, Landegren, Nils, Bryceson, Yenan, Berg, Stefan, Ekwall, Olov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051851/ https://www.ncbi.nlm.nih.gov/pubmed/33892926 http://dx.doi.org/10.1016/j.jaci.2021.03.034 |
Ejemplares similares
-
Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'
por: Landegren, Nils, et al.
Publicado: (2019) -
Molecular Mechanisms Regulating Cytotoxic Lymphocyte Development and Function, and Their Associations to Human Diseases
por: Krzewski, Konrad, et al.
Publicado: (2014) -
Neuroinflammation Associated With Inborn Errors of Immunity
por: Lindahl, Hannes, et al.
Publicado: (2022) -
Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer
por: Carlsten, Mattias, et al.
Publicado: (2023) -
The Successful Application of Plasmapheresis in the Treatment of a Patient with Opsoclonus and Autoantibodies to Glutamate Receptor δ2
por: Nakamagoe, Kiyotaka, et al.
Publicado: (2017)